Table 1.
Analyzed data sets, each study code, subjects’ related disease, number of samples per condition and reference.
| Study code | Subjects disease | Number of samples | Reference |
|---|---|---|---|
| GSE19804 | Non-smoking women with NSCLC | Normal (60) vs. Cancer (60) | (Lu et al., 2010) |
| GSE10072 | Patients with lung adenocarcinoma | Normal (49) vs. Cancer (58) | (Landi et al., 2008) |
| GSE3268 | Patients with Squamous lung cancer cells | Normal (5) vs. Cancer (5) | (Wachi et al., 2005) |
| GSE108055 | Typical and atypical carcinoid, and small cell lung cancer | Normal (9) vs. Cancer (54) | (Asiedu et al., 2018) |
| E-MTAB-5231 | Patients with NSCLC | Normal (18) vs. Cancer (22) | (Willuda et al., 2017) |
| E-MTAB-3950 | Pre-invasive and Invasive Early Squamous Carcinoma | Normal (30) vs. Cancer (30) | (Koper et al., 2017) |
| GSE21411 | Interstitial lung diseases (ILDs) | Normal (12) vs. ILD (42) | (Cho et al., 2011) |
| GSE1650 | Emphysema | Normal (12) vs. Emphysema (18) | (Spira et al., 2004) |
| GSE2052 | Idiopathic pulmonary fibrosis (IPF) | Normal (11) vs. IPF (13) | (Pardo et al., 2005; Kim et al., 2006) |
| GSE113439 | Pulmonary arterial hypertension (PAH) | Normal (11) vs. PAH (15) | None publications in PubMed |